Traded Feb 18, 2026 · Filed Feb 20, 2026
A board member of MSCI spent $2M of their very own money to buy MSCI shares. 1 other person at MSCI bought some too, in the same month. Their pile of MSCI shares grew by 20%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$1,999,556
Shares × reported transaction price
$1M+
+19.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
21 days after results of Jan 28, 2026, 62 days before results of Apr 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $545.25 on Feb 18, 2026, 8% above its 52-week low and 13% below its high, after a 6% drop over the previous 30 trading days
52-week range $506.56 (Apr 7, 2025) to $624.75 (Feb 2, 2026), 33% of the way up, from 251 adjusted closes. 30 trading days earlier: $577.60 on Jan 5, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.6% | +0.6% | +6.0% |
| 30 days | -1.4% | -3.8% | +2.4% |
| 90 days | +9.3% | +10.0% | -0.7% |
| 180 days | +6.1% | +11.9% | -5.8% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.